My bet is it is very good and propels the stock up. I am in and staying in. Those afraid will bail today and feed the Hedgies cheap shares. Dumb da dumb dumb.
How could he keep the alovectin trials delaying for years?? Fraud. Why would he?? To keep his fat salary coming in while hanging his investors out to dry. If you are in, it is your turn to dry.
"Allovectin caused tumors to shrink in 4.6% of patients compared to 12.3% of patients treated with chemotherapy used as a control. The difference was actually statistically significant against allovectin.
Why safety monitors allowed the allovectin study to continue even though patients were clearly being harmed was not explained.
In a secondary analysis, the median overall survival of patients treated with allovectin was 18.6 months compared to 24.1 months for patients treated with chemotherapy.
The results of the allovectin melanoma study were delayed for years, which Vical and its supporters believed was due to the vaccine helping patients live longer. "
Shameful, VJ should be jailed not fired.
Adam Fnctupstein said " "Galenica spox confirms to me Velphoro did NOT receive NCE status, therefore $KERX can pretty much forget about getting NCE for Zerenex." " Could someone please interpret? Thank you in advance
On 1/1/14, it becomes the year that ACAD gets its drug approved. Clearly this will be a year where the price goes up. $40.00 seems easy. The elephants want in for the ride. We welcome them!!!!!!!!!!!
earth 457 - Appears you are a stupid long unwilling to discuss whether this will move the needle. Please respond only if you have something intelligent to add. (appears you should remain silent rather than removing all doubt)
Sales are 27 million. Medicare is wasting 94% of 100 million spent on tissue. Means they will now spend 6 million on tissue. If MDXG gets 50% of market this will be 3 million dollars in sales and 2.5 million on the bottom line. Is this enough to move the needle???? If you know more, please educate me. Guess on total effect on MDXG would be appreciated. Thank you
CEO - We will continue to cut people and cut the compensation of the remaining staff. This will chase off anyone who has enough talent and luck to get a job from our competitors. When we offer our customers the services of only new people who know nothing or older people who are scared stiff and not as talented as those who have left, the customers will want to jump ship. We will jack the prices on anyone foolish enough to stay with us and they will never notice the higher prices and lower service we are offering. This is a brand new approach and Cerberus assures me that it will work. They have a spread sheet that proves it. It was prepared by a whiz kid who used it to prove we would win in Vietnam.
Sentiment: Strong Sell
Why????? Because ACAD's drug is not yet approved. I guess he thinks it would be better to buy at this price after approval. I think this continues up as people realize how big the market really is. I think the approced price will be double the current price.
When is the last time you saw the SEC prove or prosecute manipulation such as Linda just pulled on you poor slobs? Like NEVER!!!!!!!!! If the results which are unblinded which she knows, are bad, NWBO will be crushed again. If you are comfortable in front of that train, that is fine by me.
She knows the results and could not wait to announce them to raise the money. They must be bad. That is why she had to manipulate the little guy by faking a pop, sucking him in, and then immediately announcing the financing she had waiting in her pocket. Shame on her.
"The information is an announcement that Phase 1/2 DCVax-Direct clinical trial for all inoperable solid tumor cancers, which is planned to begin within approximately the next sixty days, will not be blinded. This means that the results will be seen as the trial proceeds. Knowing that an efficacy endpoint is tumor shrinkage or elimination), this trial is expected to yield meaningful ongoing results by the second half of 2013."